PBM
Psyence Biomedical Ltd. Common Shares
NASDAQ: PBM · HEALTHCARE · BIOTECHNOLOGY
$6.59
+29.72% today
Updated 2026-04-30
Market cap
$16.17M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-389.98
Dividend yield
—
52W range
$2 – $75
Volume
3.0M
Psyence Biomedical Ltd. Common Shares (PBM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-74.30%
ROA
-34.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2022 | $0.00 | $8.23M | — | — | — |
| 2023 | $0.00 | $8.01M | — | — | — |
| 2024 | $0.00 | $-51.16M | — | — | — |
| 2025 | $0.00 | $1.01M | — | — | — |